BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11874260)

  • 1. Management of hepatocellular carcinoma.
    Lau WY
    J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection and liver transplantation for hepatocellular carcinoma.
    Llovet JM; Schwartz M; Mazzaferro V
    Semin Liver Dis; 2005; 25(2):181-200. PubMed ID: 15918147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of primary liver cancer in children: an appraisal of experience.
    Pham TH; Iqbal CW; Grams JM; Zarroug AE; Wall JC; Ishitani MB; Nagorney DM; Moir C
    J Pediatr Surg; 2007 May; 42(5):834-9. PubMed ID: 17502194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment of hepatocellular carcinoma.
    Singal AG; Marrero JA
    Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M; Häussinger D
    Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
    Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
    Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small hepatocellular carcinoma: current status and prospects.
    Tang ZY
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):349-53. PubMed ID: 14607706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
    Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC
    J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.